Introduction Effective strategies to increase pre-exposure prophylaxis (PrEP) uptake and continuation among adolescent girls and young women (AGYW) who engage in sex work or transactional sex are ...

Objective To validate sphingomyelin (SM) dosage in the cerebrospinal fluid (CSF) of patients affected by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and Guillain-Barré syndrome ...

GBS is a neuromuscular emergency and rare autoimmune disease that affects at least 150,000 people worldwide each year, with no FDA-approved therapies. In its acute phase, GBS rapidly progresses toward ...

BRISBANE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...

Glucocorticoid dose at the time of prophylaxis cessation was strongly associated with subsequent Pneumocystis jirovecii pneumonia risk among patients with rheumatic diseases.

Despite the use of plasma exchanges and intravenous immunoglobulins, Guillain-Barré syndrome (GBS) still carries non-negligible morbidity and mortality. Furthermore, the psychosocial consequences of ...

hDepartment of Infectious Diseases, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France iDepartment of Infectious Diseases, Hôpital Tenon, Paris, France jDepartment of Infectious ...

AI is transforming Global Business Services (GBS) from a cost-saving and process efficiency function into a strategic intelligence and innovation hub. Today, GBS plays a far bigger role. It helped ...

57.6%; P = .003) and more commonly received postoperative biologic prophylaxis within 90 days of surgery (31.3% vs. 23.6%; P = .08) compared with older patients. The two groups had comparable ...

Of these, 240 patients received TMP-SMX prophylaxis (prophylaxis group; mean age, 63.7 years; 55.8% women) within 14 days of induction therapy, and 56 patients did not receive prophylaxis (control ...